# OnCo record bp2301 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/bp2301/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "bp2301" ;
  schema:name "BP2301"@en ;
  schema:description "BP2301 is an experimental autologous CAR-T cell therapy from BrightPath Biotherapeutics, in phase 1 trials for bone and soft tissue sarcoma and gynaecological cancers."@en ;
  schema:url <https://onco.cc/drugs/bp2301/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.brightpathbio.com/pipeline/bp2301.html> ;
  onco:status "phase-1" ;
  onco:tag "pipeline" ;
  onco:modality "Autologous CAR-T cell therapy (non-viral gene transfer)" ;
  onco:targets <https://onco.cc/targets/her2/> ;
  onco:companies <https://onco.cc/companies/brightpath-biotherapeutics/> .
